All you need to know about Chemotherapy. - PowerPoint PPT Presentation

About This Presentation
Title:

All you need to know about Chemotherapy.

Description:

All you need to know about Chemotherapy. Lynne Cormode What is Chemotherapy? Systemic treatment against malignant cells to try and prevent growth, invasion ... – PowerPoint PPT presentation

Number of Views:151
Avg rating:3.0/5.0
Slides: 17
Provided by: cancerdun
Category:

less

Transcript and Presenter's Notes

Title: All you need to know about Chemotherapy.


1
All you need to know about Chemotherapy.
  • Lynne Cormode

2
What is Chemotherapy?
  • Systemic treatment against malignant cells to try
    and prevent growth, invasion, metastasis and
    eventual death of patients.
  • Initially discovered after WW1 when soldiers
    exposed to nitrogen mustard were observed to have
    had a improvement in solid tumour size.

3
Chemotherapy Intent / Terms
  • Adjuvant
  • To reduce cancer recurrence
  • Neo-Adjuvant
  • To down stage tumour prior to surgery or radical
    treatment
  • Palliative
  • To reduce cancer load thereby improving symptoms
    and prognosis
  • Radical
  • Curative treatment
  • Concomitant
  • Combined modality treatment (Chemo/radiotherapy)
  • Regime
  • Single / Combination Drugs
  • Cycle
  • Varies from weekly to 12 weekly
  • Dose
  • Body surface area i.e. mg/m2 (Dubois Dubois)
  • Renal excretion i.e. AUC (Area under the curve)

4
Chemotherapy Forms / Types
  • Oral
  • Intravenous
  • Bolus / Infusional
  • Central / Peripheral
  • Locally
  • Intratheccal
  • Intraperitoneal / Intravesical
  • Topical
  • Intra-arterial (limb perfusion)
  • Subcutaneous or Intramuscular
  • Classic chemotherapy
  • Immunotherapy
  • Biological / Molecular targeted therapy

5
Modes of Action - General
  • Inhibition of cell multiplication via
  • Macromolecular synthesis and function i.e. DNA /
    RNA / Proteins
  • Cytoplasmic signalling
  • Cell membrane receptor synthesis, expression and
    function
  • Cellular environment

6
The Cell Cycle
  • Interphase
  • G1 (presysnthesis gap)
  • S (synthesis of DNA)
  • G2 (postsynthesis gap)
  • Mitosis
  • M (cell division)
  • Prophase
  • Sister chromatids condense
  • Mitotic spindle assembles
  • Nuclear envelope breaks down
  • Metaphase
  • Microtubles align chromosomes
  • Centromeres halfway between spindle poles
  • Anaphase
  • Separation of sister chromatids at centromere
    moving towards poles
  • Cytokinesis (cell division) starts
  • Telophase
  • Nuclear membranes reforms
  • Chromosomes become extended
  • Cytokinesis completes

7
Traditional Chemotherapy Classes
ANTIMETABOLITES
PODOFYLOTOXINS
TAXANES
ANTITUMOUR ANTIBIOTICS
ANTIMICROTUBULE AGENTS
ANTRACYCLINES
CHEMOTHERAPY
CAMPTOTHECINES
VINCA ALKALOIDS
ALKYLATING AGENTS
PLATINUM DRUGS
NITROSOUREAS
8
Antimetabolites nucleoside analogues /
antagonists
FOLIC ACID
Methotrexate inhibits DHFR
PURINES Guanine Adenine
PYRIMIDINES Cytosine Thymine Uracil
TETRAHYDROFOLIC ACID
5FU Capecitabine Cytarabine Mercaptopurine Azathio
prine Fludarabine inhibit Thymidylate synthase
NUCLEOTIDES
DNA REPLICATION
9
Antitumour Antibiotics
  • Topoisomerases are essential enzymes that
    maintain the topology of DNA. Inhibtion
    interferes with both transcription and
    replication of DNA by upsetting proper DNA
    supercoiling.
  • Cell cycle specfic G1 and S phase
  • Type I topoisomerase inhibitors,
    Camptothecins (Irinotecan, Topotecan)
  • Type II topoisomerase inhibitors,
    Epipodopyllinotoxins (Etoposide)
    Antracyclines (Doxorubicin, Daunorubicin)
    also induce O2 free radicals that break DNA
    strands inhibiting replication
  • Others include Actinomycin D, Mitomycin C,
    Bleomycin

10
Antimicrotubule Agents
  • Prevent microtubule function therefore preventing
    the separation of chromatids.
  • Cell cycle dependant M (anaphase)
  • Taxanes (Paclitaxel Docetaxel) causes
    hyperstabilisation of microtubules
  • Vinca Alkaloids (Vincristine, Vinblastine,
    Vinorelbine) inhibits the assembly of tubulin
    into microtubules

11
Alkylating agents
  • Ability to alkylate many nucleophilic function
    groups causing the formation of covalent bonds
    (cross linking of DNA)
  • Non cell cycle specific
  • Platinum drugs (Oxaliplatin, Cisplatin,
    Carboplatin) renally excreted
  • Nitroureas (Carmustine, Lomustine, Semustine)
    highly lipid soluble i.e. cross BBB
  • Others Cyclophosphamide, Dacarbazine,
    Procarbazine, Melphalan, Busulphan, Chlorambucil.

12
Hormones / Cytokines
  • Prednisolone / Dexamethasone
  • Tamoxifen
  • Aromatase Inhibitors (Letrozole, Anastrozole)
  • Gonadotropin releasing hormone agonists (Zoladex)
  • Interferon alpha

13
Monoclonal Antibodies
  • Designed to target highly expressed tumour
    specific antigens thereby increasing the immune
    response to the tumour cell.
  • Rituximab (CD20)
  • Cetuximab (Epidermal Growth Factor Receptor 1)
  • Transtuzumab (Human Epidermal growth factor
    Receptor 2)
  • Bevacizumab (Vascular Endothelial Growth Factor)
  • Tyrosine Kinase Inhibitors
  • Imatinib (Philadelphia chromosome, Bcr-Abl TKI)
  • Erlotinib (EGFR inhibitor)
  • Sunitinib (multiple receptor inhibitors inc
    VEGFR, PDGFR)

14
Chemotherapy Toxicities 1
  • Bone Marrow Suppression
  • Neutropenia
  • Anaemia
  • Thrombocytopenia
  • GI
  • Nausea / Vomiting
  • Mucositis
  • Reproductive
  • Skin / Hair
  • Palmar plantar erythodysthesia
  • Sun sensitivity
  • Extravasation
  • Rashes
  • Alopecia (scalp cooling)
  • Nephrotoxicity
  • Hepatic toxicity

15
Chemotherapy Toxicities 2
  • Neurotoxicity
  • Peripheral neuropathy
  • Ototoxicity
  • Constipation
  • Cardiac toxicity
  • Coronary vasospasm
  • Reduced LVEF
  • Bladder toxicity
  • Haemorrhagic cystitis

16
Practical Issues
  • Ward admissions
  • Neutropenic sepsis
  • Symptomatic myelosupression
  • Dehydration
  • Cardiac events
  • Extravasations
  • Anaphylactoid reactions
  • Chemotherapy spillage policy
Write a Comment
User Comments (0)
About PowerShow.com